DL

Daniel Leblanc

Chief Technology Officer

Ensoma

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Ensoma
Industry
research
Employees
98.0
Seniority
C suite
Total Funding
205000000.0
Latest Funding
Series B

Technologies

Mimecast Outlook Google Cloud Hosting Microsoft Office 365 Nginx Mobile Friendly Google Tag Manager Google Font API Vimeo WordPress.org Google Analytics Render Remote

Keywords

biotechnology research genomic medicine in vivo treatments hemopoietic stem cells gene engineering genetic therapies disease treatment one-time therapy off-the-shelf therapies viral delivery system dna delivery crispr technology gene insertion gene editing cell therapy chronic granulomatous disease sickle cell disease oncological therapies solid tumors multi-lineage immune cells patient-centric solutions scalable manufacturing proprietary gene integration systems therapeutic cell engineering immune system restoration hsc mobilization precision medicine clinical trials gene therapy infusion biotechnology innovation therapeutic payloads personalized medicine blood disorders adaptive immune response patient experience safety & efficacy long-term treatment solutions biopharmaceuticals ex vivo gene therapy hsc engineering novel drug delivery gene therapeutic platform biological therapies synthetic biology academic collaborations therapeutic strategies massive scalability disease-modifying treatments clinical data validation biomarkers for efficacy holistic patient care health care health wellness & fitness hospital & health care biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans